Antitrust suit against GSK, Bioval to continue
Pharma Compliance Alert, March 25, 2009
GlaxoSmithKline (GSK) will have to defend itself against a lawsuit claiming the company prevented generic competition for its antidepressant Wellbutrin by filing sham patent lawsuits.
GSK and Biovail, a Canadian firm that partnered with GSK to promote an extended release version of Wellbutrin, asked to have the suit dismissed because the plaintiffs failed to show a conspiracy. The actions of the two companies could have been viewed as merely parallel conduct that could have occurred independently, they argued.
U.S. District Judge Mary A. McLaughlin issued a split ruling, dismissing one claim, but allowing the others to go forward. McLaughlin refused to dismiss the plaintiffs’ claims of conspiracy to monopolize and concerted action in restraint of trade. She granted Biovail’s motion to dismiss the substantive monopolization claim, but denied GSK’s motion to dismiss the same claim.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Searched